Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: KVUE

Kenvue Inc.

Consumer Defensive | Household & Personal Products

Market prices for KVUE are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$0.86

Kenvue Inc. (NYSE: KVUE) is a household and personal products company. Figures from SEC EDGAR; updated 2026-10-19 09:29 UTC.

What Kenvue Inc. does

Kenvue is a global consumer health company that was separated from Johnson & Johnson and became an independent public company in 2023. The company sells over-the-counter medicines and health-related products through a portfolio of well-known brands including Tylenol, Aveeno, Neutrogena, and Listerine across more than 165 countries. Its products are organized into three segments: Self Care, Skin Health and Beauty, and Essential Health, allowing the company to serve consumers in daily health and wellness routines.

Summarized from Kenvue Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$0.86
Return on equity13.66%
Debt/equity0.13

Revenue, margins & earnings

FY2021 Net income: $2.08BFY2021 Taxes & interest: $842MFY2021 Operating expenses: $5.50BFY2021 Cost of revenue: $6.63B$15.1BFY2021FY2022 Net income: $2.06BFY2022 Taxes & interest: $611MFY2022 Operating expenses: $5.61BFY2022 Cost of revenue: $6.67B$14.9BFY2022FY2023 Net income: $1.66BFY2023 Taxes & interest: $848MFY2023 Operating expenses: $6.13BFY2023 Cost of revenue: $6.80B$15.4BFY2023FY2024 Net income: $1.03BFY2024 Taxes & interest: $811MFY2024 Operating expenses: $7.12BFY2024 Cost of revenue: $6.50B$15.5BFY2024FY2025 Net income: $1.47BFY2025 Taxes & interest: $944MFY2025 Operating expenses: $6.38BFY2025 Cost of revenue: $6.33B$15.1BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-06
  • 2026-10-06General CounselAward35,754$615.0K
  • 2026-10-06CFO & CAOTax withholding-5,566$95.7K
  • 2026-10-06Chief Scientific OfficerAward24,732$425.4K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Kenvue Inc. do?

Kenvue is a global consumer health company that was separated from Johnson & Johnson and became an independent public company in 2023.

When did KVUE last file with the SEC?

Kenvue Inc.'s most recent SEC filing on record is a SCHEDULE 13G/A filed 2026-08-06. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-19 09:29 UTC. This page is also available as JSON at /api/data?ticker=KVUE and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for KVUE and 5,000+ tickers.

Create a free account — keep KVUE
For your agent
GET /api/data?ticker=KVUE

This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt